| Date Checked | 2025-12-21 23:26:05 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | BLCO |
| AssetType | Common Stock |
| Name | Bausch + Lomb Corp |
| Description | Bausch + Lomb Corporation is a prominent global leader in eye health, headquartered in Vaughan, Canada, dedicated to enhancing vision health through a diverse range of innovative and high-quality products. The company’s extensive portfolio spans contact lenses, lens care solutions, surgical products, and pharmaceutical offerings that address various ocular conditions. With a strong focus on research and development, Bausch + Lomb leverages cutting-edge technologies to improve consumer experiences and optimize patient outcomes. Its robust global presence and unwavering commitment to quality position Bausch + Lomb as a critical player in the ophthalmic market, driving transformative advancements in eye care solutions. |
| CIK | 1860742 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | MEDICAL INSTRUMENTS & SUPPLIES |
| Address | 520 APPLEWOOD CRESCENT, VAUGHAN, ON, CANADA, L4K 4B4 |
| OfficialSite | https://www.bausch.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 5985807000 |
| EBITDA | 544000000 |
| PERatio | 0 |
| PEGRatio | 0.699 |
| BookValue | 18.16 |
| DividendPerShare | None |
| EPS | -0.86 |
| RevenuePerShareTTM | 14.09 |
| ProfitMargin | -0.0613 |
| OperatingMarginTTM | 0.0625 |
| ReturnOnAssetsTTM | 0.0053 |
| ReturnOnEquityTTM | -0.045 |
| RevenueTTM | 4976000000 |
| GrossProfitTTM | 2958000000 |
| DilutedEPSTTM | -0.86 |
| QuarterlyEarningsGrowthYOY | -0.886 |
| QuarterlyRevenueGrowthYOY | 0.071 |
| AnalystTargetPrice | 17.25 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 3 |
| AnalystRatingHold | 10 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | - |
| ForwardPE | 16.92 |
| PriceToSalesRatioTTM | 1.203 |
| PriceToBookRatio | 0.93 |
| EVToRevenue | 2.134 |
| EVToEBITDA | 20.86 |
| Beta | 0.617 |
| 52WeekHigh | 18.55 |
| 52WeekLow | 10.45 |
| 50DayMovingAverage | 15.75 |
| 200DayMovingAverage | 14.12 |
| SharesOutstanding | 354190000 |
| SharesFloat | 42456700 |
| PercentInsiders | 89.010 |
| PercentInstitutions | 11.289 |
| ExDividendDate | None |
| dateChecked | 2025-12-21 23:26:05 |
| fresh | 1 |